Bonesupport Holding AB (publ) (2B4.F)

EUR 28.02

(-1.06%)

EBITDA Summary of Bonesupport Holding AB (publ)

  • Bonesupport Holding AB (publ)'s latest annual EBITDA in 2023 was 28.93 Million SEK , up 155.99% from previous year.
  • Bonesupport Holding AB (publ)'s latest quarterly EBITDA in 2024 Q3 was 42.83 Million SEK , up 35.49% from previous quarter.
  • Bonesupport Holding AB (publ) reported an annual EBITDA of -54.34 Million SEK in 2022, up 30.91% from previous year.
  • Bonesupport Holding AB (publ) reported an annual EBITDA of -72.39 Million SEK in 2021, up 16.32% from previous year.
  • Bonesupport Holding AB (publ) reported a quarterly EBITDA of 42.83 Million SEK for 2024 Q3, up 35.49% from previous quarter.
  • Bonesupport Holding AB (publ) reported a quarterly EBITDA of 2.39 Million SEK for 2024 Q1, up 1518.41% from previous quarter.

Annual EBITDA Chart of Bonesupport Holding AB (publ) (2023 - 2016)

Created with Highcharts 11.1.0YearsEBITDA20162017201820192020202120222023-200000000 EUR-150000000 EUR-100000000 EUR-50000000 EUR0 EUR50000000 EUR

Historical Annual EBITDA of Bonesupport Holding AB (publ) (2023 - 2016)

Year EBITDA EBITDA Growth
2023 28.93 Million SEK 155.99%
2022 -54.34 Million SEK 30.91%
2021 -72.39 Million SEK 16.32%
2020 -90.09 Million SEK 38.17%
2019 -150.27 Million EUR 16.73%
2018 -172.25 Million EUR -73.4%
2017 -109.7 Million EUR -6.1%
2016 -96.57 Million EUR 0.0%

Peer EBITDA Comparison of Bonesupport Holding AB (publ)

Name EBITDA EBITDA Difference
SCHOTT Pharma AG & Co. KGaA 227.64 Million EUR 87.288%
Carl Zeiss Meditec AG 502.77 Million EUR 94.244%
Fielmann Aktiengesellschaft 403.8 Million EUR 92.834%
Gerresheimer AG 400.56 Million EUR 92.776%
Sartorius Aktiengesellschaft 920.1 Million EUR 96.855%
Sartorius Aktiengesellschaft 920.1 Million EUR 96.855%